Filing Details

Accession Number:
0001209191-21-043137
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-24 18:44:06
Reporting Period:
2021-06-22
Accepted Time:
2021-06-24 18:44:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879407 Arrowhead Pharmaceuticals Inc. ARWR Pharmaceutical Preparations (2834) 460408024
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1799357 James Hassard 177 E Colorado Blvd
Ste 700
Pasadena CA 91105
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-22 3,625 $89.22 105,750 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.